Skip to content

Prevention of Nosocomial Bacteremia Among Zambian Neonates

Prevention of Nosocomial Bacteremia and Mortality Among Neonates at a Tertiary Referral Center in Zambia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02386592
Enrollment
9410
Registered
2015-03-12
Start date
2015-09-01
Completion date
2017-07-31
Last updated
2017-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Sepsis, Neonatal Mortality

Brief summary

The purpose of this study is to estimate the burden of disease, identify risk factors associated with nosocomial bacteremia among neonates and assess the efficacy of low-cost measures targeted to known and suspected nosocomial BSI (bloodstream) risk factors, the investigators propose to study the impact of a novel package of infection control interventions on nosocomial bacteremia and mortality among neonates at a tertiary care center in sub-Saharan Africa.

Detailed description

The study is an18 month prospective quasi-experimental evaluation of nosocomial bacteremia and mortality among hospitalized neonates and will consist of a 6-month baseline period to capture the incidence and all-cause mortality of nosocomial BSIs, a 1-month implementation period of low-cost infection control strategies (including alcohol-based hand rub \[AHR\], 2% chlorhexidine gluconate \[CHG\], hospital staff education and text message-based reminders of infection control recommendation) and an 11-month intervention period. All neonates admitted to the neonatal intensive care unit (NICU) of the University Teaching Hospital (UTH) in Lusaka, Zambia during the study period will be eligible for study enrollment. This study will determine the capacity of an innovative bundle of low cost, simple and locally available interventions that leverage new technologies and expand application of highly effective interventions in order to reduce the incidence of nosocomial bacteremia among NICU patients in a developing country setting.

Interventions

All enrolled neonates admitted to the NICU during the implementation and intervention periods will undergo CHG bathing (sparing head and face) at the time of admission at and thereafter once weekly.

BEHAVIORALHand hygiene (HH)

Alcohol hand rub will be produced in the hospital pharmacy and will be readily available in the NICU (via wall-mounted dispensers) throughout the intervention period. Hand hygiene among NICU physicians and nurses will actively be promoted through the intervention period.

BEHAVIORALInfection control training

All NICU healthcare workers will receive infection prevention training which will involve structure training on HH, universal precautions, neonatal skin antisepsis and peripheral IV placement and line care.

OTHERInfection control reminders via SMS text

Infection control practice reminders will be sent to NICU healthcare workers on a daily basis via SMS messages.

Sponsors

University Teaching Hospital, Lusaka, Zambia
CollaboratorOTHER
Zambia Center for Applied Health Research and Development
CollaboratorOTHER
Children's Hospital of Philadelphia
CollaboratorOTHER
Boston University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Hours to 28 Days
Healthy volunteers
No

Inclusion criteria

* Neonates admitted to the study site NICU during the study period (including both inborn and outborn neonates)

Exclusion criteria

* Neonates without documented birth date * Parent or guardian unavailable or unwilling to provide consent

Design outcomes

Primary

MeasureTime frameDescription
All-cause neonatal mortality in hospitalized neonates18 monthsin hospitalized neonates at University Teaching Hospital (UTH), a large tertiary referral center, in Zambia before and after the introduction of low-cost infection-control interventions.

Secondary

MeasureTime frameDescription
Incidence of nosocomial bacteremia in hospitalized neonates18 monthsIncidence of nosocomial bacteremia in hospitalized neonates at UTH before and after the introduction of low-cost infection-control interventions.
Attributable risk of maternal, neonatal, hospital factors and nosocomial bacteremia among hospitalized neonates18 monthsMeasure the attributable risk of maternal, neonatal and hospital factors as well as invasive procedures on nosocomial bacteremia among neonates hospitalizedat UTH
Prevalence of nosocomial bacteremia caused by MDR-GNR infections among hospitalized neonates18 monthsPrevalence of nosocomial bacteremia caused by MDR-GNR infections among neonates at UTH.

Countries

Zambia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026